Vyndaqel Generic Name & Formulations
Tafamidis meglumine 20mg; soft gelatin caps.
Transthyretin (TTR) stabilizer.
Treatment in adults with cardiomyopathy of wild type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce cardiovascular mortality and cardiovascular-related hospitalization.
Vyndaqel Dosage and Administration
Swallow whole. 80mg once daily. Not substitutable with Vyndamax on a per mg basis.
Vyndaqel Boxed Warnings
Pregnancy. Advise females of reproductive potential to consider pregnancy planning and prevention. Nursing mothers: not recommended.
May potentiate BCRP substrates (eg, methotrexate, rosuvastatin, imatinib); monitor and may need to adjust dose of substrate.
Vyndaqel Adverse Reactions
Vyndaqel Clinical Trials
Vyndaqel Patient Counseling